Sort by
Refine Your Search
-
Postdoctoral position in Bioinformatics/Computational Biology (m/f/d) (full-time position 100 % ~ 38
of the university hospitals in Germany. The group of Prof. Dr. med. Kaan Boztug at the Clinic of Pediatric Immunology and Rheumatology (Centre of Pediatric, University Hospital Bonn) offers a Postdoctoral position in
-
the Core Unit for Stem Cell Technology under the direction of Prof. Michael Ziller, Dr. Yotam Menuchin-Lasowski and Prof. Tanja Kuhlmann at the Faculty of Medicine of the University of Münster
-
, microbiology, or computational science. Further information about available projects can be obtained by email to Prof. Franziska Faber (franziska.faber@uni-wuerzburg.de ) and Prof. Jörg Vogel (joerg.vogel@uni
-
with you on board! RESEARCH PROJECT: Prof. Rutsch's research group investigates the molecular basis, pathogenetic principles, and therapeutic options for ectopic calcifications. We are currently looking
-
the future of the University! > Referenz-no.: 25167 >Application deadline: 15.01.2026 Hiring is done by the Central University Administration. Your contact for further information: Jun.-Prof. Dr. Ani
-
Job advertisement no. 135/2025 The department of Microbial Immune Regulation, led by Prof. Dr. Till Strowig, at the Helmholtz Centre for Infection Research (HZI), is offering the position of a
-
: access to the DKFZ International Postdoc Program and DKFZ Career Service with targeted offers for your personal development to further develop your talents Contact: Prof. Dr. Michele Wessa Phone: +49 (0
-
Clinical Cooperation Unit (headed by Prof. Dr. med. Johannes Betge) aims to identify cancer vulnerabilities and uncover mechanisms of treatment resistance by using patient-derived cancer models and high
-
. The Institute of Molecular Medicine II, headed by Prof. Dr. Philipp Lang, focuses on the molecular basis of infections and immune responses and the development of new therapeutic options in connection with
-
Clinical Cooperation Unit (headed by Prof. Dr. med. Johannes Betge) aims to identify cancer vulnerabilities and uncover mechanisms of treatment resistance by using patient-derived cancer models and high